Leonard Kruimer
Chairman bij BIOINVENT INTERNATIONAL AB
Vermogen: 2 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Leonard Kruimer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.
33
| Extinct | Pharmaceuticals: Major | 33 |
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Biotechnology | 30 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Pharmaceuticals: Major | 16 | |
Pricewaterhouse & Co.
12
| Extinct | Miscellaneous Commercial Services | 12 |
| Public Company | Biotechnology | 5 | |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands.
3
| Extinct | Pharmaceuticals: Major | 3 |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands.
3
| Subsidiary | Biotechnology | 3 |
T.I.P. Europe Ltd.
 T.I.P. Europe Ltd. Other TransportationTransportation T.I.P. Europe Ltd. engaged in the operation of warehousing and storage facilities for land transport activities. The company was founded on March 26, 1986 and was headquartered in London, the United Kingdom.
1
| Extinct | Other Transportation | 1 |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands.
1
| Holding Company | Medical/Nursing Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Leonard Kruimer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Public Communications Contact Director/Board Member | |
| SANOFI | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TIGENIX NV | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Nyenrode Business Universiteit | College/University | Graduate Degree Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SYNGENTA | Chemicals: Agricultural | Director of Finance/CFO Corporate Secretary | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| University of Amsterdam | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer General Counsel Chief Operating Officer | |
| University of Lund | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Utrecht | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Basel | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| International Institute for Management Development | College/University | Undergraduate Degree Masters Business Admin | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
Aescap Venture Management BV
 Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Founder Private Equity Investor | |
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer Corporate Officer/Principal | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chairman | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman Sales & Marketing | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| MENDUS AB | Biotechnology | Director/Board Member Chairman | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Biotechnology | Director/Board Member Director/Board Member | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Founder General Counsel | |
| INVENTIVA | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ACTICOR BIOTECH SAS | Biotechnology | Chairman Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder |
Statistieken
Internationaal
| Nederland | 10 |
| Verenigde Staten | 8 |
| Frankrijk | 7 |
| Zwitserland | 7 |
| Verenigd Koninkrijk | 6 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 15 |
| Finance | 3 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 504 |
| Corporate Officer/Principal | 195 |
| Independent Dir/Board Member | 148 |
| Chairman | 102 |
| Chief Executive Officer | 79 |
Sterkste connecties
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Jane M. Birgitta Stymne Göransson | 50 |
| Alain Munoz | 38 |
| Alf Gunnar Martin Nicklasson | 31 |
| Nanna Liebach Lüneborg | 29 |
| Alain Parthoens | 29 |
| Catherine Moukheibir | 29 |
| Jeffrey Berkowitz | 26 |
| Thomas Werner | 25 |
| Thomas O. Hecht | 24 |
| Rosemary Crane | 23 |
| Bernd Seizinger | 23 |
| G. Edward Powell | 22 |
| Vincent Ossipow | 22 |
| Michael Owen | 20 |
- Beurs
- Insiders
- Leonard Kruimer
- Bedrijfsconnecties
